These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 26844272)
1. BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer. Moor AE; Anderle P; Cantù C; Rodriguez P; Wiedemann N; Baruthio F; Deka J; André S; Valenta T; Moor MB; Győrffy B; Barras D; Delorenzi M; Basler K; Aguet M EBioMedicine; 2015 Dec; 2(12):1932-43. PubMed ID: 26844272 [TBL] [Abstract][Full Text] [Related]
2. BCL9-2 promotes early stages of intestinal tumor progression. Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997 [TBL] [Abstract][Full Text] [Related]
3. Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer. Gay DM; Ridgway RA; Müller M; Hodder MC; Hedley A; Clark W; Leach JD; Jackstadt R; Nixon C; Huels DJ; Campbell AD; Bird TG; Sansom OJ Nat Commun; 2019 Feb; 10(1):723. PubMed ID: 30760720 [TBL] [Abstract][Full Text] [Related]
4. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
5. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma. Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365 [TBL] [Abstract][Full Text] [Related]
6. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells. de la Roche M; Worm J; Bienz M BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596 [TBL] [Abstract][Full Text] [Related]
7. AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling. Chi J; Zhang H; Hu J; Song Y; Li J; Wang L; Wang Z Cell Signal; 2020 Jan; 65():109419. PubMed ID: 31526829 [TBL] [Abstract][Full Text] [Related]
8. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798 [TBL] [Abstract][Full Text] [Related]
9. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells. Venugopal A; Subramaniam D; Balmaceda J; Roy B; Dixon DA; Umar S; Weir SJ; Anant S Mol Carcinog; 2016 Nov; 55(11):1503-1516. PubMed ID: 26331352 [TBL] [Abstract][Full Text] [Related]
10. miR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2. Chen HY; Lang YD; Lin HN; Liu YR; Liao CC; Nana AW; Yen Y; Chen RH Sci Rep; 2019 Jul; 9(1):9687. PubMed ID: 31273221 [TBL] [Abstract][Full Text] [Related]
11. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
13. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression. Talla SB; Brembeck FH Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361 [TBL] [Abstract][Full Text] [Related]
14. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells. Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569 [TBL] [Abstract][Full Text] [Related]
15. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301 [TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling. Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623 [TBL] [Abstract][Full Text] [Related]
17. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling. Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922 [TBL] [Abstract][Full Text] [Related]
18. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer. Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166 [TBL] [Abstract][Full Text] [Related]
19. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling. Hoffmans R; Basler K Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272 [TBL] [Abstract][Full Text] [Related]
20. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells. Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]